X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45) 45
female (39) 39
oncology (36) 36
aged (32) 32
male (28) 28
middle aged (28) 28
adult (24) 24
index medicus (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
chemotherapy (21) 21
cancer (16) 16
italy (13) 13
treatment outcome (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
care and treatment (11) 11
carcinoma (10) 10
cisplatin (10) 10
colorectal neoplasms - drug therapy (10) 10
deoxycytidine - analogs & derivatives (10) 10
disease-free survival (10) 10
oxaliplatin (10) 10
survival analysis (10) 10
aged, 80 and over (9) 9
survival (9) 9
5-fluorouracil (8) 8
breast neoplasms - drug therapy (8) 8
colorectal carcinoma (8) 8
deoxycytidine - administration & dosage (8) 8
fluorouracil - administration & dosage (8) 8
prognosis (8) 8
research (8) 8
colorectal cancer (7) 7
combination (7) 7
elderly patients (7) 7
fluorouracil (7) 7
gemcitabine (7) 7
irinotecan (7) 7
leucovorin - administration & dosage (7) 7
neoplasm staging (7) 7
organoplatinum compounds - administration & dosage (7) 7
1st-line treatment (6) 6
antimetabolites, antineoplastic - administration & dosage (6) 6
capecitabine (6) 6
cisplatin - administration & dosage (6) 6
colorectal neoplasms - pathology (6) 6
disease progression (6) 6
folinic acid (6) 6
quality of life (6) 6
survival rate (6) 6
therapy (6) 6
analysis (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
breast cancer (5) 5
breast neoplasms - pathology (5) 5
camptothecin - analogs & derivatives (5) 5
clinical trials (5) 5
drug administration schedule (5) 5
leucovorin (5) 5
lung neoplasms - drug therapy (5) 5
metastasis (5) 5
neoplasm metastasis (5) 5
phase-iii (5) 5
retrospective studies (5) 5
time factors (5) 5
vinorelbine (5) 5
camptothecin - administration & dosage (4) 4
carcinoma, non-small-cell lung - drug therapy (4) 4
colorectal neoplasms - mortality (4) 4
deoxycytidine - adverse effects (4) 4
drug therapy (4) 4
expression (4) 4
fluorouracil - therapeutic use (4) 4
follow-up studies (4) 4
hematology, oncology and palliative medicine (4) 4
leucovorin - therapeutic use (4) 4
medicine (4) 4
medicine, research & experimental (4) 4
metaanalysis (4) 4
paclitaxel (4) 4
quality-of-life (4) 4
settore med/06 - oncologia medica (4) 4
adenocarcinoma - drug therapy (3) 3
adjuvant chemotherapy (3) 3
adolescent (3) 3
antimetabolites, antineoplastic - adverse effects (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic agents, phytogenic - administration & dosage (3) 3
biochemistry, genetics and molecular biology (3) 3
biomarkers, tumor - genetics (3) 3
camptothecin - therapeutic use (3) 3
cancer research (3) 3
carboplatin (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
cell biology (3) 3
chemotherapy, adjuvant (3) 3
cisplatin - adverse effects (3) 3
clinical-trials (3) 3
combination regimen (3) 3
cooperative-oncology-group (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2000, Volume 18, Issue 13, pp. 2529 - 2536
Journal Article
Scientific Reports, ISSN 2045-2322, 11/2014, Volume 4, Issue 1, pp. 6828 - 6828
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 08/2010, Volume 10, Issue 1, pp. 458 - 458
Background: Prognostic factors in patients who are diagnosed with T4 breast carcinomas are widely awaited. We here evaluated the clinical role of some... 
AMERICAN-JOINT-COMMITTEE | CANCER PATIENTS | APOPTOSIS | OVEREXPRESSION | METASTASIS | CELL MOTILITY | ONCOLOGY | SURVIVIN | TUMOR | H-PRUNE | CHEMOTHERAPY | Cyclin D1 - metabolism | Follow-Up Studies | Microtubule-Associated Proteins - genetics | Microtubule-Associated Proteins - metabolism | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Immunoenzyme Techniques | Tumor Suppressor Protein p53 - genetics | Breast Neoplasms - metabolism | Mitogen-Activated Protein Kinase 1 - genetics | Biomarkers, Tumor - metabolism | Adult | Female | Retrospective Studies | Inhibitor of Apoptosis Proteins | Mitogen-Activated Protein Kinase 3 - genetics | Tumor Suppressor Protein p53 - metabolism | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Survivin | Breast Neoplasms - drug therapy | Carrier Proteins - genetics | Breast Neoplasms - genetics | Carrier Proteins - metabolism | Gene Amplification | Cyclin D1 - genetics | Mitogen-Activated Protein Kinase 3 - metabolism | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy | Aged | Biomarkers, Tumor - genetics | Neoplasm Staging | Mitogen-Activated Protein Kinase 1 - metabolism | Genetic markers | Patient outcomes | Analysis | Development and progression | Breast cancer | Genetic aspects | Research | Gene expression | Tumor proteins
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 2/2009, Volume 135, Issue 2, pp. 217 - 226
Oxaliplatin combined with either fluorouracil/leucovorin (OXAFAFU) or capecitabine (OXXEL) has a demonstrated activity in metastatic colorectal cancer... 
Oxaliplatin | Medicine & Public Health | Hematology | Capecitabine | Colorectal carcinoma | Internal Medicine | Cancer Research | Oncology | Randomized trial | OXXEL regimen | OXAFAFU regimen | 1ST-LINE TREATMENT | LEUCOVORIN | PHASE-II | FOLINIC ACID | CHEMOTHERAPY | 5-FLUOROURACIL | FINAL REPORT | ONCOLOGY | IRINOTECAN | ELDERLY-PATIENTS | CARCINOMA | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Rectal Neoplasms - physiopathology | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antimetabolites, Antineoplastic - administration & dosage | Colonic Neoplasms - physiopathology | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Adenocarcinoma - physiopathology | Time Factors | Colorectal Neoplasms - drug therapy | Adult | Female | Rectal Neoplasms - pathology | Rectal Neoplasms - drug therapy | Colorectal Neoplasms - mortality | Colonic Neoplasms - mortality | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Adenocarcinoma - drug therapy | Disease Progression | Rectal Neoplasms - mortality | Colorectal Neoplasms - physiopathology | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Survival Analysis | Quality of Life | Aged | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Adenocarcinoma - mortality | Care and treatment | Oncology, Experimental | Colorectal cancer | Diarrhea | Leucovorin | Metastasis | Research | Cancer | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 06/2010, Volume 116, Issue S11, pp. 2736 - 2740
Breast cancer represents the most common cancer among women in Italy. In the last decade, an increase in incidence and a decrease in mortality from breast... 
clinical aspects | pathologic aspects | inflammatory breast cancer | breast cancer epidemiology | SURVIVAL | MORTALITY | STAGE | EUROPE | INSTITUTE | ONCOLOGY | CARCINOMA INCIDENCE | SURVEILLANCE | PROVINCE | END RESULTS PROGRAM | EPIDEMIOLOGY
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 3/2008, Volume 100, Issue 6, pp. 388 - 398
Journal Article